The use of systemic glucocorticoids (e.g., oral prednisone or intravenous methylprednisolone), typically prescribed for severe asthma exacerbations or refractory cases, has been associated with hippocampal atrophy through chronic activation of glucocorticoid receptors (Brown et al. This evidence concerns the gene NR3C1 and hippocampal atrophy.